Pharmaceutical care for severe and critically ill patients with COVID-19 / 浙江大学学报·医学版
Journal of Zhejiang University. Medical sciences
;
(6): 158-169, 2020.
Article
Dans Chinois
| WPRIM
| ID: wpr-828558
ABSTRACT
Severe and critically ill patients with coronavirus disease 2019 (COVID-19) were usually with underlying diseases, which led to the problems of complicated drug use, potential drug-drug interactions and medication errors in special patients. Based on ( 6), and -19 , we summarized the experience in the use of antiviral drugs, corticosteroids, vascular active drugs, antibacterial, probiotics, nutrition support schemes in severe and critically ill COVID-19 patients. It is also suggested to focus on medication management for evaluation of drug efficacy and duration of treatment, prevention and treatment of adverse drug reactions, identification of potential drug-drug interactions, individualized medication monitoring based on biosafety protection, and medication administration for special patients.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Sujet Principal:
Antiviraux
/
Pneumopathie virale
/
Maladie grave
/
Hormones corticosurrénaliennes
/
Infections à coronavirus
/
Soutien nutritionnel
/
Probiotiques
/
Utilisations thérapeutiques
/
Traitement médicamenteux
/
Pandémies
Limites du sujet:
Humains
langue:
Chinois
Texte intégral:
Journal of Zhejiang University. Medical sciences
Année:
2020
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS